Nervous System Drug-by-design: Formulation May Slow Parkinson’s, Alzheimer’s, Huntington’s

A researcher in Israel is “building” a new drug, L803-MTS, to treat a number of central nervous system diseases, and it also shows promise against Parkinson’s, Huntington’s and diabetes.